These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 20478371)

  • 1. The transit of dosage forms through the small intestine.
    Yuen KH
    Int J Pharm; 2010 Aug; 395(1-2):9-16. PubMed ID: 20478371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of small intestinal transit and colon arrival times of non-disintegrating tablets administered in the fasted state.
    Pišlar M; Brelih H; Mrhar A; Bogataj M
    Eur J Pharm Sci; 2015 Jul; 75():131-41. PubMed ID: 25769525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meal-induced acceleration of tablet transit through the human small intestine.
    Fadda HM; McConnell EL; Short MD; Basit AW
    Pharm Res; 2009 Feb; 26(2):356-60. PubMed ID: 18982248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The transit of dosage forms through the colon.
    Wilson CG
    Int J Pharm; 2010 Aug; 395(1-2):17-25. PubMed ID: 20576492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific aspects of gastro-intestinal transit in children for drug delivery design.
    Bowles A; Keane J; Ernest T; Clapham D; Tuleu C
    Int J Pharm; 2010 Aug; 395(1-2):37-43. PubMed ID: 20478372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Site-specific drug delivery systems within the gastro-intestinal tract: from the mouth to the colon.
    Pinto JF
    Int J Pharm; 2010 Aug; 395(1-2):44-52. PubMed ID: 20546856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are chitosan formulations mucoadhesive in the human small intestine? An evaluation based on gamma scintigraphy.
    Säkkinen M; Marvola J; Kanerva H; Lindevall K; Ahonen A; Marvola M
    Int J Pharm; 2006 Jan; 307(2):285-91. PubMed ID: 16310992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of pharmaceutical excipients on small intestinal transit.
    Adkin DA; Davis SS; Sparrow RA; Huckle PD; Phillips AJ; Wilding IR
    Br J Clin Pharmacol; 1995 Apr; 39(4):381-7. PubMed ID: 7640144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transit of pharmaceutical dosage forms through the small intestine.
    Davis SS; Hardy JG; Fara JW
    Gut; 1986 Aug; 27(8):886-92. PubMed ID: 3732895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral modified-release formulations in motion: the relationship between gastrointestinal transit and drug absorption.
    Varum FJ; Merchant HA; Basit AW
    Int J Pharm; 2010 Aug; 395(1-2):26-36. PubMed ID: 20546855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of polyethylene glycol 400 on gastrointestinal transit: implications for the formulation of poorly-water soluble drugs.
    Basit AW; Newton JM; Short MD; Waddington WA; Ell PJ; Lacey LF
    Pharm Res; 2001 Aug; 18(8):1146-50. PubMed ID: 11587486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sustained delivery of intact drug to the colon: mesalamine formulation and temporal gastrointestinal transit analysis.
    Chuong MC; Christensen JM; Ayres JW
    Pharm Dev Technol; 2009; 14(1):116-25. PubMed ID: 18821272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastroretentive dosage forms.
    Moës AJ
    Crit Rev Ther Drug Carrier Syst; 1993; 10(2):143-95. PubMed ID: 8370085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of formulation excipients on human intestinal transit.
    Schulze JD; Ashiru DA; Khela MK; Evans DF; Patel R; Parsons GE; Coffin MD; Basit AW
    J Pharm Pharmacol; 2006 Jun; 58(6):821-5. PubMed ID: 16734983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastrointestinal transit of dosage forms in the pig.
    Davis SS; Illum L; Hinchcliffe M
    J Pharm Pharmacol; 2001 Jan; 53(1):33-9. PubMed ID: 11206190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
    Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
    Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concentration-dependent effects of polyethylene glycol 400 on gastrointestinal transit and drug absorption.
    Schulze JD; Waddington WA; Eli PJ; Parsons GE; Coffin MD; Basit AW
    Pharm Res; 2003 Dec; 20(12):1984-8. PubMed ID: 14725363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formulation strategies for absorption windows.
    Davis SS
    Drug Discov Today; 2005 Feb; 10(4):249-57. PubMed ID: 15708743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism-based prediction of particle size-dependent dissolution and absorption: cilostazol pharmacokinetics in dogs.
    Willmann S; Thelen K; Becker C; Dressman JB; Lippert J
    Eur J Pharm Biopharm; 2010 Sep; 76(1):83-94. PubMed ID: 20554023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastrointestinal transit and functionality of multiple unit dosage forms.
    Podczeck F
    Int J Pharm; 2010 Aug; 395(1-2):1. PubMed ID: 20452411
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.